-
1
-
2Academic Journal
Authors: А.А. Баранов, О.В. Крестьянинов, Д.А. Хелимский, А.Г. Бадоян, Р.У. Ибрагимов, А.П. Горгулько, С.Н. Манукян, Ш.Ш. Зайнобидинов
Source: Патология кровообращения и кардиохирургия, Vol 26, Iss 3 (2022)
Subject Terms: аортальный стеноз, атриовентрикулярная блокада, транскатетерная имплантация аортального клапана, электрокардиостимулятор, Surgery, RD1-811
File Description: electronic resource
-
3Academic Journal
Authors: A. Pevzner V., E. Kuchinskaya A., V. Kiktev G., G. Kheimets I., А. Певзнер В., Е. Кучинская А., В. Киктев Г., Г. Хеймец И.
Source: Rational Pharmacotherapy in Cardiology; Vol 17, No 2 (2021); 315-322 ; Рациональная Фармакотерапия в Кардиологии; Vol 17, No 2 (2021); 315-322 ; 2225-3653 ; 1819-6446
Subject Terms: vasovagal syncope, bradicardia, asystole, pacemaker, tilt-test, implantable loop recorder, midodrine, вазовагальный обморок, брадикардия, асистолия, электрокардиостимулятор, тилт-тест, имплантируемый петлевой регистратор, мидодрин
File Description: application/pdf
Relation: https://www.rpcardio.com/jour/article/view/2142/2155; Shen W, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS Guideline for the evaluation and man-agement of patients with syncope. JACC. 2017;70(5):e39-e110. DOI:10.1016/j.jacc.2017.03.003.; Ganzeboom KS, Mairuhu G, Reitsma JB, et al. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years. J Cardiovasc Electrophysiol. 2006;17(11):1172-76. DOI:10.1111/j.1540-8167.2006.00595.x.; Chen LY, Shen WK, Mahoney DW, et al. Prevalence of syncope in a population aged more than 45 years.Am. J. Med. 2006;119(12):1088.e1-7. DOI:10.1016/j.amjmed.2006.01.029.; Kenny R.A., Brignole M., Dan G.A., et al. Syncope Unit: rationale and requirement-the European Heart Rhythm Association position statementendorsed by the Heart Rhythm Society. Europace. 2015;17:1325-40. DOI:10.1093/europace/euv115.; ПевзнерА.В., КучинскаяЕ.А. Вазова-гальныеобмороки. В кн.: Чазов И.Е., Голицын С.П., редакторы. Руководство по нарушениям ритма сердца. М.: ГЭОТАР-Медиа; 2008: с. 223-44). ISBN: 978-5-9704-1643-3.; Brignole M, Menozzi C, Del Rosso A, et al. New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Europace. 2000;2:66-76. DOI:10.1053/eupc.1999.0064.; Brignole M, Moya A, de Lange F, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39:1-69. DOI:10.1093/eurheartj/ehy037.; Benditt DG, Ferguson DW, Grub BP, et al. Tilt table testing for assessing syncope. American college of cardiology. J Am Coll Cardiol. 1996;28:263-75. DOI:10.1016/0735-1097(96)00236-7.; Певзнер А.В., Кучинская Е.А., Вершута Е.В. и др. Возможности длительной ортостатической и велоэргометрической проб при дифференциальной диагностике синкопальных состояний не-ясного генеза. Терапевтический Архив. 2004;11:23-7].; Krahn A, Klein G, Yee R, et al. Randomized Assessment of Syncope Trial. Conventional Diagnostic Testing Versus a Prolonged Monitoring Strategy. Circulation. 2001;104:46. DOI:10.1161/01.cir.104.1.46.; Farwell D, Freemantle N, Sulke A. Use of implantable loop recorders in the diagnosis and management of syncope. Eur Heart J. 2004;25(14):1257-63. DOI:10.1016/j.ehj.2004.03.010.; Brignole M, Vardas P, Hoffman E, et al. Indications for the use of diagnostic implantable and external ECG loop recorders. Europace. 2009;11:671-87. DOI:10.1093/europace/eup097.; Moya A, Brignole M, Menozzi C, et al. on behalf of the International Study on Syncope ofUncertain Etiology (ISSUE) Investigators. Mechanism of syncope in patients with isolated syncope and in patients with tilt positive syncope. Circulation. 2001;104:1261-67. DOI:10.1161/hc3601.095708.; Van Dijk N, Quartieri F, Blanc JJ, et al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the physical counterpressure maneuvers trial (PC-trial). J Am Coll Cardiol. 2006;48:1652-57. DOI:10.1016/j.jacc.2006.06.059.; Кучинская Е.А., Певзнер А.В. Изменение образа жизни как метод лечения вазовагальных обмороков. Кардиология. 2020;60(1):93-8. DOI 10.18087/cardio.2020.1.n776.; Brignole M, Menozzi C, Bottoni N, et al. Mechanisms of syncope caused by transient bradycardia and the diagnostic value of electrophysiologic testing and cardiovascular reflexivity maneuvers. Am J Cardiol. 1995;76(4):273-8. DOI:10.1016/s0002-9149(99)80080-0.; Lacroix D, Kouakam C, Klug D, et al. Asystolic cardiac arrest during Head-Up Tilt Test: incidence and therapeutic implications. Pacing Clin Electrophysiol. 1997;20:2746-54. DOI:10.1111/j.1540-8159.1997.tb05432.x.; Baron-Esquivias G, Pedrote A, Cayuela A, et al. Long-term outcome of patients with asystole induced by head-up tilt test. Eur. Heart J. 2002;23:483-89. DOI:10.1053/euhj.2001.2900.; Вершута Е.В. Певзнер А.В., Ермишкин В.В., и др. Спектральные показатели вариабельности ритма сердца у больных вазовагальными обмороками по данным 5-минутных записей ЭКГ. Терапевтический Архив. 2009;4:17-21.; Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013;15(8):1070-18. DOI:10.1093/europace/eut206.; Ревишвили А.Ш., Шляхто Е.В., Попов С.В., и др. Клинические рекомендации по проведению электрофизиологических исследований, катетерной абляции и применению имплантируемых антиаритмических устройств (2017) [цитировано 02.01.2020]. Доступно на: https://vnoa.ru/upload/Recomendation_2017_30_10_2017_HR.pdf.; Varosy PD, Chen LY, Miller AL, et al. Pacing as a Treatment for Reflex-Mediated (Vasovagal, Situational, or Carotid Sinus Hypersensitivity) Syncope: A Systematic Review for the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope. J Am Coll Cardiol. 2017;70:664-79. DOI:10.1016/j.jacc.2017.03.004.; Conolly S, Sheldon R, Thorpe K, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope (VPS II): a randomized trial. JAMA. 2003;289(17):2224-29. DOI:10.1001/jama.289.17.2224.; Raviele A, Giada F, Menozzi C, et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J. 2004;25(19):1741-48. DOI:10.1016/j.ehj.2004.06.031.; Brignole M, Menozzi C, Moya A, et al. Pacemaker therapy in patients with neurally-mediated syncope and documented asystole. Third international study on syncope of unknown etiology (IS- SUE-3): a randomized trial. Circulation. 2012;125(21):2566-71. DOI:10.1161/CIRCULATIONA-HA.111.082313.; Ryan D, Nick S, Colette S, et al. Carotid sinus syndrome, should we pace? A multicentre, randomised control trial (Safepace 2). Heart. 2010;96(5):347-51. DOI:10.1136/hrt.2009.176206.; Brignole M, Donateo P, Tomaino M, et al. Benefit of pacemaker therapy in patients with presumed neurally mediated syncope and documented asystole is greater when tilt test is negative an analysis from the third international study on syncope of uncertain etiology (ISSUE-3).Circ Arrhythm Elec-trophysiol. 2014;7:10-16. DOI:10.1161/CIRCEP.113.001103.; Хеймец Г.И., Певзнер А.В., Рогоза А.Н., Голицын С.П. Пятиминутная пассивная ортостатическая проба в алгоритме обследования больных с обмороками. Кардиологический Вестник. 2017,12(3):70-4.; Occhetta E, Bortnik A, Audoglio R, et al. Closed loop stimulation in patients of vasovagal syncope. Inotropy controlled pacing in vasovagal syncope (INVASY): a multicentre randomized, single blind, controlled study. Europace. 2004 6:538-47. DOI:10.1016/j.eupc.2004.08.009.; Rattanawong P, Riangwiwat T, Chongsathidkiet P, et al. Closed-looped stimulation cardiac pacing for recurrentvasovagal syncope: A systematic review and meta-analysis.J Arrhythm. 2018;34(5):556- 64. DOI:10.1002/joa3.12102.; Brignole M, Tomaino M, Aerts A, et al. Benefit of dual-chamber pacing with Closed Loop Stimulation in tilt-induced cardio-inhibitory reflex syncope (BIOSync trial): study protocol for a randomized controlled trial. Trials. 2017;18(1):208. DOI:10.1186/s13063-017-1941-4.; Brignole M, Ammirati F, Arabia F, et al. Assessment of a standardized algorithmfor cardiac pacing in older patients affected by severe unpredictable reflex syncopes. Eur Heart J. 2015;36(24):1529- 35. DOI:10.1093/eurheartj/ehv069.; Soteriades E.S., Evans J.C., Larson M.G., et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347(12):878-85. DOI:10.1056/NEJMoa012407.; Певзнер А.В., Кучинская Е.А., Альбицкая К.В. Эффективность компрессионной терапии нижних конечностей при лечении больных вазовагальными обмороками. Терапевтический Архив. 2007;79(1):52-5.; Sheldon R, Raj S, Rose S, et al. Fludrocortisone for the prevention of vasovagal syncope.A randomized, placebo-controlled trial. J Am Col Cardil. 2016;68(1):1-9. DOI:10.1016/j.jacc.2016.04.030.; Kaufmann H, Saadia D, Voustianiouk A. Midodrine in neurally mediated syncope: a double-blind, randomized crossover study. Ann Neurol. 2002;52(3):342-45. DOI:10.1002/ana.10293.; Ward CR, Gray IC, Gilroy JJ, Kenny PA. Midodrine: a role in the treatment of neurocardiogenic syncope. Heart. 1998;79(1):45-9. DOI:10.1136/hrt.79.1.45.; Romme J, van Dijk N, Go-Schon I, et al. Effectiveness of midodrine treatment in patients with recur- rentvasovagal syncope not responding to non-pharmacological treatment (STAND-trial). Europace. 2011;13(11):1639-47. DOI:10.1093/europace/eur200.; Кучинская Е.А., Певзнер А.В., Вершута Е.В. и др. Результаты применения мидодрина для лечения больных с вазовагальными обмороками. Терапевтический Архивю 2004;76(8):38-41.; Певзнер А.В., Кучинская Е.А., Вершута Е.В., и др. Успешное лечение мидодрином вазовагальных обмороков, протекающих с асистолией. Клиническая Медицина. 2004;82(9):53-6.; Sheldon R, Lei L, Guzman J, Kus T. A proof of principle study of atomoxetine for the prevention of vasovagal syncope: the prevention of syncope trial VI. Europace. 2019;21:1733-41. DOI:10.1093/eu-ropace/euz250.; https://www.rpcardio.com/jour/article/view/2142
-
4Academic Journal
Authors: A. T. Kalybekova, S. S. Rakhmonov, V. L. Lukinov, A. M. Chernyavskyi, А. Т. Калыбекова, С. С. Рахмонов, В. Л. Лукинов, А. М. Чернявский
Source: Siberian Journal of Clinical and Experimental Medicine; Том 36, № 2 (2021); 107-114 ; Сибирский журнал клинической и экспериментальной медицины; Том 36, № 2 (2021); 107-114 ; 2713-265X ; 2713-2927
Subject Terms: изолированная левопредсердная аблация, biatrial ablation, long-standing persistent form, ischemic heart disease, pacemaker, isolated left atrial ablation, биатриальная аблация, длительно персистирующая форма, ишемическая болезнь сердца, электрокардиостимулятор
File Description: application/pdf
Relation: https://www.sibjcem.ru/jour/article/view/1198/625; Hindricks G., Potpara T., Dagres N., Arbelo E., Bax J.J., Blomström- Lundqvist C. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2021;42(5):373–498. DOI:10.1093/eurheartj/ehaa612.; Badhwar V., Rankin J.S., Damiano R.J. Jr., Gillinov A.M., Bakaeen F.G., Edgerton J.R. et al. The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation. Ann. Thorac. Surg. 2017;103(1):329–341. DOI:10.1016/j.athoracsur.2016.10.076.; Stulak J.M., Suri R.M., Burkhart H.M., Daly R.C., Dearani J.A., Greason K.L. et al. Surgical ablation for atrial fibrillation for two decades: are the results of new techniques equivalent to the Cox maze III procedure? J. Thorac. Cardiovasc. Surg. 2014;147(5):1478–1486. DOI:10.1016/j.jtcvs.2013.10.084.; Uschner D., Schindler D., Hilgers R., Heussen N. randomizeR: An R Package for the Assessment and Implementation of Randomization in Clinical Trials. Journal of Statistical Software. 2018;85(8):1–22. DOI:10.18637/jss.v085.i08.; Knuuti J., Wijns W., Saraste A., Capodanno D., Barbato E., Funck-Brentano C. et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur. Heart J. 2020;41(3):407–477. DOI:10.1093/eurheartj/ehz425.; Calkins H., Hindricks G., Cappato R., Kim Y.H., Saad E.B., Aguinaga L. et al. Document Reviewers: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018;20(1):e1–e160. DOI:10.1093/europace/eux274.; Калыбекова А.Т., Чернявский А.М. Сравнительная характеристика биатриальной и левопредсердной аблации в хирургическом лечении длительно персистирующей формы фибрилляции предсердий у пациентов с сочетанной патологией сердца. Анналы аритмологии. 2019;16(4):194–203. DOI:10.15275/annaritmol.2019.4.2.; Калыбекова А.Т., Рахмонов С.С., Чернявский А.М., Алмазов А.А., Нарциссова Г.П., Мироненко С.П. Одномоментное применение хирургической радиочастотной аблации и аортокоронарного шунтирования у больных длительно персистирующей формой фибрилляции предсердий и ишемической болезнью сердца. Патология кровообращения и кардиохирургия. 2019;23(4):37–46. DOI:10.21688/1681-3472-2019-4-37-46.; Belley-Cote E.P., Singal R.K., McClure G., Devereaux K., Brady K., An K. et al. Perspective and practice of surgical atrial fibrillation ablation: An international survey of cardiac surgeons. Europace. 2019;21(3):445–450. DOI:10.1093/europace/euy212.; Hald M.O., Lauritzen D.J., Heiberg J., Juhl W., Moss E., Vodstrup H.J. Biatrial ablation vs. Pulmonary vein isolation in atrial fibrillation patients undergoing cardiac surgery: a retrospective study. Scand. Cardiovasc. J. 2020;55(2):116–121. DOI:10.1080/14017431.2020.1846775.; Li H., Lin X., Ma X., Tao J., Zou R., Yang S. et al. Biatrial Versus Isolated Left Atrial Ablation in Atrial Fibrillation: A Systematic Review and Meta-Analysis. BioMed Res. Int. 2018;2018:3651212. DOI:10.1155/2018/3651212.; Pecha S., Schäfer T., Yildirim Y., Ahmadzade T., Willems S., Reichenspurner H. et al. Predictors for permanent pacemaker implantation after concomitant surgical ablation for atrial fibrillation. J. Thorac. Cardiovas. Surg. 2014;147(3):984–988. DOI:10.1016/j.jtcvs.2013.03.012.; Meng Z., Dong J., Jiang F. Biatrial ablation versus left atrial ablation with bipolar system in the surgical treatment of atrial fibrillation with mitral valve disease. Chinese Journal of Thoracic and Cardiovascular Surgery. 2014;30(1):482–485.; Gualis J., Castaño M., Martínez-Comendador J.M., Marcos J.M., Martín C., Estévez-Loureiro R. et al. Biatrial vs. isolated left atrial cryoablation for the treatment of long-lasting permanent atrial fibrillation. Midterm recurrence rate. Arch. Cardiol. Méx. 2016;86(2):123–129. DOI:10.1016/j.acmx.2015.09.005.; Calo L., Lamberti F., Loricchio M. L., De Ruvo E., Colivicchi F., Bianconi L. et al. Left atrial ablation versus biatrial ablation for persistent and permanent atrial fibrillation: A prospective and randomized study. J. Am. Coll. Cardiol. 2006;47(12):2504–2512. DOI:10.1016/j.jacc.2006.02.047.; Onorati F., Mariscalco G., Rubino A.S., Serraino F., Santini F., Musazzi A. et al. Impact of lesion sets on mid-term results of surgical ablation procedure for atrial fibrillation. J. Am. Coll. Cardiol. 2011;57(8):931–940. DOI:10.1016/j.jacc.2010.09.055.; Albage A., Peterffy M., Kallner G. Learning what works in surgical cryoablation of atrial fibrillation: Results of different application techniques and benefits of prospective follow-up. Interact. Cardiovasc. Thorac. Surg. 2011;13(5):480–484. DOI:10.1510/icvts.2011.280735.; McCarthy P.M., Kruse J., Shalli S., Ilkhanoff L., Goldberger J.J., Kadish A.H. et al. Where does atrial fibrillation surgery fail? Implications for increasing effectiveness of ablation. J. Thorac. Cardiovacs. Surg. 2010;139(4):860–867. DOI:10.1016/j.jtcvs.2009.12.038.; Soni L.K., Cedola S.R., Cogan J., Jiang J., Yang J., Takayama H. et al. Right atrial lesions do not improve the efficacy of a complete left atrial lesion set in the surgical treatment of atrial fibrillation, but they do increase procedural morbidity. J. Thorac. Cardiovacs. Surg. 2013;145(2):356–363. DOI:10.1016/j.jtcvs.2012.09.091.; Kim J.B., Bang J.H., Jung S.H., Choo S.J., Chung C.H., Lee J.W. Left atrial ablation versus biatrial ablation in the surgical treatment of atrial fibrillation. Ann. Thorac. Surg. 2011;92(4):1397–1404. DOI:10.1016/j.athoracsur.2011.05.066.; Breda J.R., Breda A.N.C.R., Ragognette R.G., Machado L.N., Neff C.B., de Matos L.L. et al. Comparison of uniatrial and biatrial radiofrequency ablation procedures in atrial fibrillation: Initial results. Heart Surg. Forum. 2011;14(5):E271–E275. DOI:10.1532/HSF98.20101119.; Geuzebroek G.S.C., Ballaux P.K.E.W., Van Hemel N.M., Kelder J.C., Defauw J.A.M.T. Medium-term outcome of different surgical methods to cure atrial fibrillation: Is less worse? Interact. Cardiovasc. Thorac. Surg. 2008;7(2):201–206. DOI:10.1510/icvts.2007.159889.; Cappabianca G., Ferrarese S., Tutino C., Corazzari C., Matteucci M., Mantovani V. et al. Safety and efficacy of biatrial vs left atrial surgical ablation during concomitant cardiac surgery: A meta‐analysis of clinical studies with a focus on the causes of pacemaker implantation. J. Cardiovasc. Electrophysiol. 2019;30(10):2150–2163. DOI:10.1111/jce.14117.; https://www.sibjcem.ru/jour/article/view/1198
-
5Academic Journal
Authors: D A Maximkin, N V Safonov, V Y Baranovich, A G Faibushevich
Source: RUDN Journal of Medicine, Vol 21, Iss 2, Pp 227-233 (2017)
Subject Terms: электрокардиостимулятор, 03 medical and health sciences, 0302 clinical medicine, ингибирование, Medicine, электрокоагуляция, уlectrocoagulation, 3. Good health
-
6
-
7Academic Journal
Authors: О. Сапельников, А. Куликов, Д. Черкашин, И. Гришин, О. Николаева, Д. Ардус, А. Ширяев, Р. Акчурин
Source: Патология кровообращения и кардиохирургия, Vol 23, Iss 4 (2019)
Subject Terms: имплантируемый кардиовертер-дефибриллятор, имплантируемое устройство, электрокардиостимулятор, экстракция электродов, Surgery, RD1-811
File Description: electronic resource
-
8Academic Journal
Authors: Bozhko, Ya. G., Arkhipov, M. V., Molodykh, S. V., Божко, Я. Г., Архипов, М. В., Молодых, С. В.
Subject Terms: SINUS NODE DYSFUNCTION, TACHY-BRADYCARDIA SYNDROME, ATRIAL FIBRILLATION, DUAL-CHAMBER PACEMAKER, ДИСФУНКЦИЯ СИНУСОВОГО УЗЛА, СИНДРОМ ТАХИ-БРАДИКАРДИИ, ФИБРИЛЛЯЦИЯ ПРЕДСЕРДИЙ, ЭЛЕКТРОКАРДИОСТИМУЛЯТОР
File Description: application/pdf
Relation: Уральский медицинский журнал. 2019. Т. 172, № 4.; http://elib.usma.ru/handle/usma/11363
Availability: http://elib.usma.ru/handle/usma/11363
-
9Academic Journal
Authors: Bozhko, Ya. G., Arkhipov, M. V., Molodykh, S. V., Божко, Я. Г., Архипов, М. В., Молодых, С. В.
Subject Terms: SINUS NODE DYSFUNCTION, TACHY-BRADYCARDIA SYNDROME, ATRIAL FIBRILLATION, DUAL-CHAMBER PACEMAKER, ДИСФУНКЦИЯ СИНУСОВОГО УЗЛА, СИНДРОМ ТАХИ-БРАДИКАРДИИ, ФИБРИЛЛЯЦИЯ ПРЕДСЕРДИЙ, ЭЛЕКТРОКАРДИОСТИМУЛЯТОР
File Description: application/pdf
Relation: Уральский медицинский журнал. 2019. Т. 175, № 7.; http://elib.usma.ru/handle/usma/12645
Availability: http://elib.usma.ru/handle/usma/12645
-
10
-
11
-
12Academic Journal
Authors: Igor A. Kovalev, Yuri M. Belozerov, Dinara I. Sadykova, Dina R. Sabirova, Lyudmila V. Yakovleva, Zulfiya R. Khabibrakhmanova, Andrey S. Sakerin, И. А. Ковалёв, Ю. М. Белозёров, Д. И. Садыкова, Д. Р. Сабирова, Л. В. Яковлева, З. Р. Хабибрахманова, А. С. Сакерин
Contributors: Not specified, Отсутствует
Source: Pediatric pharmacology; Том 15, № 5 (2018); 365-375 ; Педиатрическая фармакология; Том 15, № 5 (2018); 365-375 ; 2500-3089 ; 1727-5776
Subject Terms: электрокардиостимулятор, atrioventricular block, children, pacemaker, атриовентрикулярная блокада, дети
File Description: application/pdf
Relation: https://www.pedpharma.ru/jour/article/view/1664/1027; Аритмии сердца: механизмы, диагностика, лечение / Под ред. В.Дж. Мандела. Пер. с англ. Т.2. — М.: Медицина; 1996. — 206 с.; Белозеров Ю.М. Детская кардиология. — М.: МЕДпрессинформ; 2004. — 525 c.; Егоров Д.Ф., Адрианов А.В. Диагностика и лечение брадикардии у детей. — СПб.: Человек; 2008. — 320 с.; Brucato A. Prevention of congenital heart block in children of SSA-positive mothers. Rheumatology. 2008;47 Suppl 3:iii35–37. doi:10.1093/rheumatology/ken153.; Walsh EP, Saul JP, Triedman JK. Cardiac arrhythmias in children and young adults with congenital heart disease. 1st ed. Philadelphia, PA, USA: LWW; 2001. 528 p.; Brugada J, Blom N, Sarquella-Brugada G, et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace. 2013;15(9):1337–1382. doi:10.1093/europace/eut082.; Allen HD, Driscoll DJ, Shaddy RE, Feltes TF. Moss & Adams’ heart disease in infants, children, and adolescents: including the fetus and young adult. Vol. 1. 7th ed. Philadelphia, PA, USA: LWW; 2008. 760 p.; Park MK. Park’s pediatric cardiology for practitioners. 6th ed. Philadelphia, PA: Mosby Elsevier; 2014. 688 p.; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA), Brignole M, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013;15(8):1070–1118. doi:10.1093/europace/eut206.; Clancy RM, Kapur RP, Molad Y, et al. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage, fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum. 2004;50(1):173–182. doi:10.1002/art.11430.; Кошелева Н.М., Алекберова З.С. Неонатальная волчанка // Современная ревматология. — 2015. — Т.9. — №4 — С. 92–97. doi:10.14412/1996-7012-2015-4-92-97.; Bader RS, Hornberger LK, Huhta JC. The perinatal cardiology handbook. 1st ed. Mosby; 2008. 526 p.; Zeigler VL, Gillette PG, editors. Practical management of pediatric cardiac arrhythmias. Hoboken, NJ, USA: Wiley-Blackwell; 2001. 416 p.; Brucato A, Jonson A, Friedmen D, et al. Proposal for a new definition of congenital complete atrioventricular block. Lupus. 2003;12(6):427–435. doi:10.1191/0961203303lu408oa.; Campbell RM, Douglas PS, Eidem BW, et al. ACC/AAP/ AHA/ASE/HRS/SCAI/SCCT/SCMR/SOPE 2014 appropriate use criteria for initial transthoracic echocardiography in outpatient pediatric cardiology: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Academy of Pediatrics, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography. J Am Coll Cardiol. 2014;64(19):2039–2060. doi:10.1016/j.jacc.2014.08.003.; Rychik J, Ayres N, Cuneo B, et al. American society of echocardiography guidelines and standards for performance of fetal echocardiography. J Am Soc Echocardiogr. 2004;17(7):803–810. doi:10.1016/j.echo.2004.04.011.; Ostensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006;8(3):209. doi:10.1186/ar1957.; Ruffatti A, Milanesi O, Chiandetti L, et al. A combination therapy to treat second-degree anti-Ro/La-related congenital heart block: a strategy to avoid stable third-degree heart block? Lupus. 2012;21(6):666–671. doi:10.1177/0961203311430969.; Saxena A, Izmirly PM, Mendez B, et al. Prevention and treatment in utero of autoimmune associated congenital heart block. Cardiol Rev. 2014;22(6):263–267. doi:10.1097/CRD.0000000000000026.; Pelliccia A, Fagard R, Bjørnstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26(14):1422–1445. doi:10.1093/eurheartj/ehi325.; Zipes DP, Link MS, Ackerman MJ, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 9: arrhythmias and conduction defects: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2412–2423. doi:10.1016/j.jacc.2015.09.041; https://www.pedpharma.ru/jour/article/view/1664
-
13Academic Journal
Authors: Kovalenko L.A., Dolginov D.M., Kovalchuk A.S., Afukov I.I.
Source: Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care; Vol 7, No 3 (2017); 86-90 ; Российский вестник детской хирургии, анестезиологии и реаниматологии; Vol 7, No 3 (2017); 86-90 ; 2587-6554 ; 2219-4061
Subject Terms: poisoning, verapamil, metaprolol, eternal cardiac pacemaker, отравление, верапамил, метапролол, внешний электрокардиостимулятор
File Description: application/pdf
-
14Academic Journal
Authors: V. V. Plechev, I. A. Nagaev, I. M. Karamova, M. V. Nazarov, I. Sh. Sagitov, I. E. Nikolaeva, В. В. Плечев, И. А. Нагаев, И. М. Карамова, М. В. Назаров, И. Ш. Сагитов, И. Е. Николаева
Source: Creative surgery and oncology; № 3 (2012); 70-73 ; Креативная хирургия и онкология; № 3 (2012); 70-73 ; 2076-3093 ; 2307-0501 ; 10.24060/2076-3093-2012-0-3
Subject Terms: баллонная ангиопластика, artery, infarct related artery, pacemaker, stenting, balloon angioplasty, инфаркт-ответственная артерия, электрокардиостимулятор, стентирование
File Description: application/pdf
Relation: https://www.surgonco.ru/jour/article/view/139/140; Статистическое обозрение. Ежеквартальный журнал Федеральной службы государственной статистики. 2011. №1. С. 76.; ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction // Circulation 2004. Vol. 110. P. 588-636.; Alpert J.S. Conduction disturbances: temporary and permanent pacing in patients with acute myocardial infarction. In: Gersh B.J., Rahimtoola S.H., editors // Acute myocardial infarction. New York: Chapman and Hall, 1997. P. 354-367.; Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) // J Am. Coll. Cardiol, 2004. Vol.44. P. 211-221.; Antman EM. In Braunwald E, Zipes L,Libby P, Bonow R. ST-elevation myocardial infarction: management // Heart disease: Saunders Company, 2005. P. 1167–1226.; Aplin M, Engstrom T, Vejlstrup NG, Clemmensen P, Torp-Pedersen C, Kober L. Prognostic importance of complete atrioventricular block complicating acute myocardial infarction (TRACE Study Group) // Am. J. Cardiol. 2003. Vol. 92. P. 853-856.; Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation: recommendations of the Task Force of the European Society of Cardiology // Eur. Heart J. 2000.Vol. 21. P. 1406-1432.; Cüneyt Narin, Ahmet Ozkara , Ahmet Soylu , Erdal Ege , Akif Düzenli , Ali Sarigül , Mehmet Yeniterzi . The Effect of Coronary Revascularization on New-Onset Complete Atrioventricular Block Due to Acute Coronary Syndrome // The Heart Surgery Forum. 2009.Vol. 12. – P. 30-34.; Goldberg R.J., Zevallos J.C., Yarzebski J., Alpert J.S., Gore J.M., Chen Z. et al. Prognosis of acute myocardial infarction complicated by complete heart block (the Worcester Heart Attack Study) // Am. J. Cardiol. 1992. Vol. 69. P. 1135-1141.; Ganz L.I., Antman E.M. Cardiac arrhythmias during acute myocardial infarction // Management of cardiac arrhythmias, 2004. P. 419-426.; Meine TJ, Al-Khatib SM, Alexander JH, Granger CB, White HD, Kilaru R, et al. Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy // Am. Heart J. 2005. Vol. 149. P. 670-674.; Rosenfeld L.E. Bradyarrhythmias, abnormalities of conduction, and indications for pacing in acute myocardial infarction // Yale University School of Medicine, New Haven, Connecticut. Cardiol. Clin. – 1988. – Vol. 6(1).P. 49-61.; Spencer F.A., Jabbour S., Lessard D., Yarzebski J., Ravid S., Zaleskas V. et al. Two-decade-long trends (1975-1997) in the incidence, hospitalization, and longterm death rates associated with complete heart block complicating acute myocardial infarction: a community-wide perspective // Am. Heart J. 2003. Vol. 145. P. 500-507.; https://www.surgonco.ru/jour/article/view/139
-
15Academic Journal
-
16
-
17
-
18Academic Journal
Authors: D. R. Sabirova, V. T. Saidova, L. M. Mirolyubov, Д. Р. Сабирова, В. Т. Саидова, Л. М. Миролюбов
Source: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 59, № 6 (2014); 70-73 ; Российский вестник перинатологии и педиатрии; Том 59, № 6 (2014); 70-73 ; 2500-2228 ; 1027-4065 ; undefined
Subject Terms: электрокардиостимулятор, congenital heart diseases, complete atrioventricular block, Morgagni—Adams—Stokes attack, pacemaker, врожденные пороки сердца, полная АВ-блокада, приступ Морганьи—Адамса—Стокса
File Description: application/pdf
Relation: https://www.ped-perinatology.ru/jour/article/view/281/320; Kertesz N.J., Friedman R.A., Fenrich A.L. et al. The incidence of perioperative arrhythmias. In: S. Balaji, EC. Gillette, C.L. Case (eds). Cardiac arrhythmias after surgery for congenital heart disease. Arnold, 2001; 50—63.; Weindling S.N., Saul J.P., Gamble W.J. et al. Duration of complete atrioventricular block after congenital heart disease surgery. Am J Cardiol 1998; 82: 4: 525—527.; Бокерия О.Л. Пери- и послеоперационные аритмии у детей: причины возникновения, подходы к лечению. Анналы аритмологии2005; 1: 25—35. (BokeriyaO.L. Peri- and postoperative arrhythmias in children: development causes and treatment strategies. Annaly aritmologii 2005; 1: 25—35.); Бокерия О.Л. Современные подходы к лечению остро развившихся аритмий у детей. Детские болезни сердца и сосудов 2004; 1: 5—13. (Bokeriya О. L. Current approaches to the treatment of acute arrhythmias in children. Detskie bolezni serdca i sosudov 2004; 1: 5—13.); Кушаковский М.С. Аритмии сердца. Руководство для врачей. СПб.: Гиппократ, 1992; 544. (Kushakovskij M. S. Cardial arrhythmias. Guide for physicians. SPb.: Hippocrates 1992; 544.); Школьникова М.А. Жизнеугрожающие аритмии у детей. М., 1999; 230. (Shkol'nikova M.A. Life-threatening arrhythmias in children. Moscow, 1999; 230.)
-
19Academic Journal
Authors: O. S. Groznova, D. A. Kharlamov, S. B. Artemyeva, G. E. Rudenskaya, T. A. Adyan, O. P. Ryzhkova, О. С. Грознова, Д. А. Харламов, С. Б. Артемьева, Г. Е. Руденская, Т. А. Адян, О. П. Рыжкова
Source: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 59, № 1 (2014); 66-70 ; Российский вестник перинатологии и педиатрии; Том 59, № 1 (2014); 66-70 ; 2500-2228 ; 1027-4065 ; undefined
Subject Terms: лечение, X-linked Emery—Dreifuss myopathy, emerin gene, clinical symptoms, cardiomyopathy, atriomegaly, cardiac rhythm disturbances, cardiac conduction disturbance, pacemaker, treatment, прогрессирующая мышечная дистрофия Эмери—Дрейфуса Х-сцепленная, ген эмерин, клинические симптомы, кардиомиопатия, атриомегалия, нарушение ритма сердца, нарушение проводимости сердца, электрокардиостимулятор
File Description: application/pdf
Relation: https://www.ped-perinatology.ru/jour/article/view/36/67; Astejada M.N., Goto K., Nagano A. et al. Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan. Acta Myol 2007; 26: 3: 159—164.; Грознова О.С., Новиков П.В., Белозеров Ю.М. и др. Диагностка и тактика лечения поражения сердца при аутосомно-доминантной прогрессирующей мышечной дистрофии Эмери-Дрейфуса. Рос вестн перинатол и педиат 2007; 3; 42—47. (Groznova O.S., Novikov P.V., Belozerov Ju.M., Rudenskaja G.E., Tverskaja S.A. Cardiac lesion in Emery-Dreifus autosome-dominant progressive musculad dystrophy: treatment and policy. Ros vestn perinatol i pediat 2007; 3; 42—47.); Puckelwartz M., McNally E.M. Emery–Dreifuss muscular dystrophy. Handb Clin Neurol 2011; 101: 155—166.; Perrot A., Spuler S., Geier C. et al. Cardiac manifestations of muscular dystrophies. Z Kardiol 2005; 94: 5: 312—320.; Finsterer J., Stöllberger C. Primary myopathies and the heart. Scand Cardiovasc J 2008; 42: 1: 9—24.; Wożakowska-Kapłon B., Bąkowski D. Atrial paralysis due to progression of cardiac disease in a patient with Emery– Dreifuss muscular dystrophy. Cardiol J 2011; 18: 2: 189—193.; Грознова О.С., Новиков П.В. Ранняя диагностика поражения сердца при Х-сцепленной форме мышечной дистрофии Эмери–Дрейфусса у детей. Рос вестн перинатол и педиат 2011; 1; 27—32. (Groznova O.S., Novikov P.V. Early diagnosis of cardiac lesion in X-linked Emery-Dreifus muscular dystrophy in children. Ros vestn perinatol i pediat 2011; 1; 27—32.); Cestan R., LeJonne N.I. Une myopathie avec retractions familiales. Nouv. Iconogr Salpetr 1902; 15: 38—52.; Emery A.E.H. X-linked muscular dystrophy with early contractures and cardiomyopathy (Emery–Dreifuss type). Clin Genet 1987; 32: 360—367.; Yates J.R.W., Warner J.P., Smith J.A. et al. Emery–Dreifuss muscular dystrophy: linkage to markers in distal Xq28. J Med Genet 1993; 30: 108—111.; Bonne G., Leturcq F., Ben Yaou R. Emery–Dreifuss Muscular Dystrophy. R.A. Pagon, T.D. Bird, C.R. Dolan et. al. (Eds). Source GeneReviews™ [Internet]. Seattle (WA): University of Washington. Seattle 2013; 427.; Carboni N., Mura M., Mercuri E. et al. Cardiac and muscle imaging findings in a family with X-linked Emery–Dreifuss muscular dystrophy. Neuromuscul Disord 2012; 22: 2: 152—158.; Finsterer J., Stöllberger C., Keller H. Arrhythmia-related workup in hereditary myopathies. J Electrocardiol 2012; 45: 4: 376—384.; Parmar M.S., Parmar K.S. Emery–Dreifuss humeroperoneal muscular dystrophy: cardiac manifestations. Can J Cardiol 2012; 28: 4: 516. e1—3.; Nigro G., Russo V., Ventriglia V.M. et al. Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery–Dreifuss muscular dystrophy. Neuromuscul Disord 2010; 20: 3: 174—177.; Ishikawa K., Mimuro M., Tanaka T. Ventricular arrhythmia in X-linked Emery–Dreifuss muscular dystrophy: a lesson from an autopsy case. Intern Med 2011; 50: 5: 459—462.; Zaim S., Bach J., Michaels J. Sudden death in an Emery– Dreifuss muscular dystrophy patient with an implantable defibrillator. Am J Phys Med Rehabil 2008; 87: 4: 325—329.; Golzio P.G., Chiribiri A., Gaita F. Unexpected sudden death avoided by implantable cardioverter defibrillator in Emery Dreifuss patient. Europace 2007; 9: 12: 1158—1160.; Buckley A.E., Dean J., Mahy I.R. Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series. Heart 1999; 82: 1: 105—108.; Dickey R.P., Ziter F.A., Smith R.A. Emery–Dreifuss muscular dystrophy. J Pediat 1984; 104: 4: 555—559.; Russo V., Rago A., Palladino A. et al. P-wave duration and dispersion in patients with Emery–Dreifuss muscular dystrophy. J Investig Med 2011; 59: 7: 1151—1154.; Russo V., Rago A., Politano L. et al. Increased dispersion of ventricular repolarization in emery dreifuss muscular dystrophy patients. Med Sci Monit 2012; 18: 11: 643—647.; Грознова О.С., Чечуро В.В. Лечение кардиомиопатии у больных прогрессирующими мышечными дистрофиями. Рос вестн перинатол и педиат 2011; 2; 58—62. (Groznova O.S., Chechuro V.V. Treatment for cardiomyopathies in patients with progressive muscular dystrophies. Ros vestn perinatol i pediat 2011; 2; 58—62.); undefined
Availability: https://www.ped-perinatology.ru/jour/article/view/36
-
20Academic Journal
Authors: O. S. Groznova, G. E. Rudenskaya, T. A. Adyan, D. A. Kharlamov, О. С. Грознова, Г. Е. Руденская, Т. А. Адян, Д. А. Харламов
Source: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 60, № 4 (2015); 63-68 ; Российский вестник перинатологии и педиатрии; Том 60, № 4 (2015); 63-68 ; 2500-2228 ; 1027-4065 ; undefined
Subject Terms: электрокардиостимулятор, progressive muscular dystrophy, Emery—Dreifuss myopathy, X-linked form, cardiovascular disorders, cardiomy-opathy, arrhythmias, pacemaker, прогрессирующая мышечная дистрофия, миопатия Эмери—Дрейфуса, Х-сцепленная форма, сердечнососудистые нарушения, кардиомиопатия, нарушения ритма сердца
File Description: application/pdf
Relation: https://www.ped-perinatology.ru/jour/article/view/137/178; Finsterer J., Stollberger С. Primary myopathies and the heart. Scand Cardiovasc J 2008; 42; 1: 9-24.; Raffaele di Barletta M., Ricci E., Galluzzi G. et al. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery—Dreifuss muscular dystrophy. Am J Hum Genet 2000; 66: 1407-1412.; Manilal S., Recan D., Sewry С A. et al. Mutations in Emery-Dreifuss muscular dystrophy and their effectes on emerin protein expression. Hum Mol Genet 1998; 7: 855-864.; Puckelwartz, M., McNally EM. Emery—Dreifuss muscular; dystrophy. Handb ClinNeurol2011; 101: 155-166.; Hermans M. C, Pinto Y.M., Merkies I.S. et al. Hereditary muscular dystrophies and the heart. Neuromuscul Disord 2010; 20: 8: 479-492.; Parmar M.S., Parmar K.S. Emery—Dreifuss humeroperoneal muscular dystrophy: cardiac manifestations. Can J Cardiol 2012; 28: 4: 516.; Wessely R., Seidl S., Schomig A. Cardiac involvement in Emery—Dreifuss muscular dystrophy. Clin Genet 2005; 67: 220-223.; Ishikawa К, Mimuro М., Тапака Т. Ventricular arrhythmia in X-linked Emery-Dreifuss muscular dystrophy: a lesson from an autopsy case. Intern Med 2011; 50: 5: 459—462.; Van Berlo J.H., De Voogt W.G., Van derKooiAJ. et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med (Berl) 2005; 83: 1: 79-83.; Nigro G., Russo V, Ventriglia V.M. et al. Early onset of cardio-myopathy and primary prevention of sudden death in X-linked Emery—Dreifuss muscular dystrophy. Neuromuscul Disord 2010; 20: 3: 174-177.; Zaim S., Bach J., Michaels J. Sudden death in an Emery—; Dreifuss muscular dystrophy patient with an implantable defi-brfflator. Am J Phys Med Rehabil 2008; 87: 4: 325-329.; Golzio P.G., ChiribiriA., Gaita F. 'Unexpected' sudden death avoided by implantable cardioverter defibrfflator in Emery Dreifuss patient. Europace 2007; 9: 12: 1158-1160.; Грознова О.С, Новиков П.В. Ранняя диагностика поражения сердца при Х-сцепленной форме мышечной дистрофии Эмери—Дрейфуса у детей. Рос вестн перинатол и педиат 2011; 1; 27-32. (Groznova O.S., Novikov P.V. Early diagnosis of cardiac lesion in X-linked Emery-Dreifus muscular dystrophy in children. Ros vestn perinatol i pediat 2011; 1; 27-32.); undefined
Availability: https://www.ped-perinatology.ru/jour/article/view/137